Perceptive Advisors LLC Verona Pharma PLC Transaction History

Perceptive Advisors LLC

  • $2.39 Billion
  • Q1 2025

A detailed history of Perceptive Advisors LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Perceptive Advisors LLC holds 6,563,340 shares of VRNA stock, worth $486 Million. This represents 17.44% of its overall portfolio holdings.

Number of Shares
6,563,340
Previous 6,392,106 2.68%
Holding current value
$486 Million
Previous $297 Million 40.38%
% of portfolio
17.44%
Previous 9.9%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$44.81 - $69.63 $7.67 Million - $11.9 Million
171,234 Added 2.68%
6,563,340 $417 Million
Q4 2024

Feb 14, 2025
BUY
$28.71 - $47.02 $2.19 Million - $3.58 Million
76,173 Added 1.21%
6,392,106 $297 Million
Q3 2024

Nov 14, 2024
BUY
$15.46 - $30.16 $60 Million - $117 Million
3,882,208 Added 159.52%
6,315,933 $182 Million
Q2 2024

Aug 14, 2024
SELL
$11.48 - $17.02 $15.2 Million - $22.6 Million
-1,327,851 Reduced 35.3%
2,433,725 $35.2 Million
Q1 2024

May 15, 2024
SELL
$15.3 - $20.24 $1.6 Million - $2.12 Million
-104,638 Reduced 2.71%
3,761,576 $60.5 Million
Q4 2023

Feb 14, 2024
SELL
$11.94 - $20.47 $1.68 Million - $2.89 Million
-140,983 Reduced 3.52%
3,866,214 $76.9 Million
Q3 2023

Nov 14, 2023
SELL
$16.3 - $22.09 $6.36 Million - $8.61 Million
-389,919 Reduced 8.87%
4,007,197 $65.3 Million
Q2 2023

Aug 14, 2023
BUY
$19.41 - $23.43 $32.3 Million - $39 Million
1,663,326 Added 60.84%
4,397,116 $93 Million
Q1 2023

May 15, 2023
SELL
$18.06 - $25.27 $38.8 Million - $54.3 Million
-2,146,929 Reduced 43.99%
2,733,790 $54.9 Million
Q4 2022

Feb 14, 2023
SELL
$9.84 - $26.13 $1.64 Million - $4.35 Million
-166,545 Reduced 3.3%
4,880,719 $128 Million
Q3 2022

Nov 14, 2022
BUY
$4.14 - $13.59 $8.83 Million - $29 Million
2,132,118 Added 73.14%
5,047,264 $51.6 Million
Q2 2022

Aug 15, 2022
SELL
$3.55 - $5.06 $458,507 - $653,534
-129,157 Reduced 4.24%
2,915,146 $12.2 Million
Q1 2022

May 16, 2022
BUY
$4.82 - $6.98 $852,142 - $1.23 Million
176,793 Added 6.17%
3,044,303 $15.2 Million
Q4 2021

Feb 14, 2022
SELL
$3.91 - $7.08 $83,591 - $151,363
-21,379 Reduced 0.74%
2,867,510 $19.3 Million
Q3 2020

Nov 16, 2020
BUY
$4.45 - $10.2 $12.9 Million - $29.5 Million
2,888,889 New
2,888,889 $18 Million
Q3 2018

Nov 14, 2018
SELL
$11.65 - $14.1 $260,109 - $314,810
-22,327 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$13.66 - $21.0 $462,268 - $710,661
-33,841 Reduced 60.25%
22,327 $307,000
Q1 2018

May 15, 2018
SELL
$11.69 - $20.97 $1.68 Million - $3.02 Million
-143,832 Reduced 71.92%
56,168 $1.12 Million
Q3 2017

Nov 14, 2017
BUY
$11.96 - $16.95 $2.39 Million - $3.39 Million
200,000
200,000 $3.07 Million

Others Institutions Holding VRNA

# of Institutions
291
Shares Held
74.3M
Call Options Held
933K
Put Options Held
1.98M
View Full List

About Verona Pharma plc

VRNA Quotes by TradingView
  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $4.51B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email